PSCHvsXPHETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) and State Street SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.35% for XPH. PSCH is up 22.45% year-to-date (YTD) with -$1M in YTD flows. XPH performs worse with 12.1% YTD performance, and +$186M in YTD flows. Run a side-by-side ETF comparison of PSCH and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs XPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH XPH | +2.58%-5.42% | +1.83%-8.29% | +22.45%+12.10% | +26.77%+29.83% | +52.89%+79.04% | -9.76%+38.62% |
| Flows | PSCH XPH | -$13M-$80M | +$10M+$14M | -$1M+$186M | -$1M+$206M | -$102M+$160M | -$210M+$157M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH XPH | +16.86%+22.68% | +19.43%+23.32% | +21.81%+20.82% | +22.92%+21.10% |
| Max drawdown | PSCH XPH | -8.61%-16.58% | -15.36%-16.58% | -22.80%-23.45% | -45.76%-30.87% |
| Max drawdown duration | PSCH XPH | 65d65d | 168d65d | 488d322d | 1810d1452d |
Trading data
PSCH | XPH | |
Last sale 10/26/2026 at 1:30 PM | $54.35 | $62.90 |
| Previous close 10/23/2026 | $54.00 | $62.70 |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | XPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/26/2026 at 1:30 PM
Live
Closed
PSCH | XPH | |
|---|---|---|
| Last price | $54.35 | $62.90 |
| 1D performance | +0.65% | +0.32% |
| AuM | $173.83 M | $438.96 M |
| E/R | 0.29% | 0.35% |
Characteristics
PSCH | XPH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | State Street Investment Management |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | S&P Pharmaceuticals Select Industry Index |
| N° of holdings | 69 | 62 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | June 19, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
94.93%
Other
5.07%
XPH
USA
89.77%
Other
10.23%
Sectors
PSCH
Healthcare
100%
Other
0%
XPH
Healthcare
93.27%
Other
6.73%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.62%
XPH
Total weight of top 15 holdings out of 15
34.13%
Top 15 holdings
Data as of August 31, 2026
PSCH
Corcept Therapeutics, Inc.
5.61%
Glaukos Corp.
5.37%
Protagonist Therapeutics, Inc.
4.54%
Alkermes Plc
4.09%
TG Therapeutics, Inc.
3.69%
Teleflex, Inc.
3.06%
PTC Therapeutics, Inc.
2.99%
Ligand Pharmaceuticals, Inc.
2.87%
Merit Medical Systems, Inc.
2.68%
RadNet, Inc.
2.68%
Liquidia Corp.
2.47%
ICU Medical, Inc.
2.20%
Indivior Pharmaceuticals, Inc.
2.16%
Integer Holdings Corp.
2.14%
Concentra Group Holdings Parent, Inc.
2.07%
XPH
Amylyx Pharmaceuticals, Inc.
3.65%
Crinetics Pharmaceuticals, Inc.
3.60%
MBX Biosciences, Inc.
2.89%
Omeros Corp.
2.68%
Enliven Therapeutics, Inc.
2.28%
Nuvation Bio, Inc.
2.12%
Corcept Therapeutics, Inc.
2.11%
Eton Pharmaceuticals, Inc.
2.08%
Perrigo Co. Plc
1.91%
Edgewise Therapeutics, Inc.
1.85%
Nektar Therapeutics
1.83%
Merck & Co., Inc.
1.81%
Trevi Therapeutics, Inc.
1.80%
Tarsus Pharmaceuticals, Inc.
1.76%
Bristol Myers Squibb Co.
1.75%
Frequently asked questions about PSCH and XPH
How have the PSCH and XPH ETFs performed in 2026?
As of October 23, 2026, PSCH is up 22.45% year-to-date (YTD), while XPH has returned 12.1%. That puts PSCH better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or XPH?
Year-to-date, the PSCH ETF saw -$1M in flows, compared to +$186M for XPH.
Which ETF is more volatile: PSCH or XPH?
Over the past year, PSCH had a volatility of 19.43%, while XPH experienced 23.32%.
Which ETF is bigger: PSCH or XPH?
As of October 23, 2026, PSCH holds $173.83 M in assets under management (AUM), while XPH manages $438.96 M.
What sectors do the PSCH and XPH ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, XPH focuses on Healthcare.
What are the top holdings of the PSCH ETF and XPH ETF?
PSCH top holdings include Corcept Therapeutics, Inc., Glaukos Corp. and Protagonist Therapeutics, Inc.. XPH holds in its top three: Amylyx Pharmaceuticals, Inc., Crinetics Pharmaceuticals, Inc. and MBX Biosciences, Inc..
Which ETF is more diversified: PSCH or XPH?
PSCH holds 69 securities with 48.62% of its assets in the top 15. XPH has 62 securities and a top 15 weight of 34.13%.
Advertisement
Latest news about PSCH & XPH
Donald Trump’s Executive Orders: ETF Bulls and Bears
January 24, 2025
XPH
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
XPH
Advertisement
Advertisement
